Nordic private equity firm CapMan will sell OneMed after purchasing the company in 2006. Since that time, OneMed has made a number of acquisitions and its revenue has more than doubled from about €150 million (£125.6 million) to close to €400 million this year.
OneMed distributes consumable medical products, devices and technology in the Nordics and Eastern Europe. 3i plans to increase OneMed’s market share in northern Europe and expand it across the rest of the continent, according to a statement from the firm. The deal will also allow OneMed to access new international suppliers linked to 3i, particularly from Asia.
OneMed CEO Andreas Göthberg comments: ‘OneMed has achieved tremendous growth during the four-year period demonstrating that a company operating in a fragmented and complex market can, with the assistance of an investment partner, make great progress.’